Clinical Trials Browser

Phase 2/3 × INDUSTRY × glucose-regulated proteins × Clear all

NCT04206254 2019-12-20

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms